Are there any contraindications or usage restrictions for thiamine 100 mg, riboflavin 2.54 mg, niacinamide 100 mg, panthenol 5 mg, and methylcobalamin 125 µg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safety Profile of High-Dose B Vitamin Combination

The ingredients you've listed are generally safe at these doses, with the primary contraindication being a history of hypersensitivity to any component, though thiamine carries a rare risk of anaphylaxis with parenteral administration and niacinamide may cause dose-dependent adverse effects at this high dose (100 mg). 1

Specific Ingredient Analysis

Thiamine (100 mg)

  • Absolute contraindication: Known hypersensitivity to thiamine or any formulation ingredient 1
  • Safety margin: Your 100 mg dose is well within safe limits. Parenteral doses of 100-500 mg have been administered without toxic effects, though doses exceeding 30 mg three times daily are not efficiently utilized 1
  • Anaphylaxis risk: The risk of anaphylactic shock from parenteral thiamine is below 1 in 100,000 2. This is primarily relevant for IV administration; oral thiamine is considered safe 2
  • Clinical context: ESPEN guidelines recommend 100-300 mg/day for suspected deficiency states 3, so your 100 mg dose aligns with therapeutic recommendations

Riboflavin (2.54 mg)

  • No significant contraindications at this dose
  • Safety profile: Oral riboflavin rarely causes side effects beyond yellow-colored urine 3
  • Toxicity threshold: Repeatedly consumed pharmacologic doses above 100 mg have potential for phototoxicity and formation of hepato/cytotoxic tryptophan-riboflavin adducts 3
  • Your dose: At 2.54 mg, this is well below any concerning threshold and aligns with ESPEN recommendations of 3.6-5 mg for parenteral nutrition 3

Niacinamide (100 mg)

  • Primary concern at this dose: This is a relatively high dose that may cause adverse effects
  • Common adverse effects: GI upset, liver dysfunction, flushing (less common with niacinamide than niacin), skin rash, and fatigue 4
  • Dose-dependent effects: AEs are more common with higher doses. Regular clinical monitoring may not be indicated for doses under 1500 mg/day, but your 100 mg dose is at the upper end of typical supplementation 4
  • Safety considerations: Both niacinamide and niacin are relatively non-toxic in acute studies, though niacinamide is more toxic than niacin in acute toxicity testing 5
  • Clinical monitoring: Watch for GI symptoms and consider liver function monitoring if used long-term at this dose

Panthenol (5 mg)

  • No significant contraindications identified in the evidence
  • Safety profile: ESPEN guidelines recommend 5-15 mg for parenteral nutrition 3, so your 5 mg dose is at the lower therapeutic range
  • Generally well-tolerated with minimal adverse effect profile

Methylcobalamin (125 mcg)

  • No contraindications at this dose
  • Safety profile: Vitamin B12 is extremely safe; the primary clinical concern with elevated B12 is as a marker of underlying disease (liver disease, malignancy, kidney disease) rather than toxicity from the vitamin itself 6
  • Your dose: 125 mcg (0.125 mg) is well within normal supplementation ranges. ESPEN recommends 5-7.5 mg for parenteral nutrition 3

Key Clinical Considerations

Restrictions and monitoring:

  • Renal dysfunction: Higher doses may have reduced tolerability in patients with kidney disease 4
  • Liver disease: Monitor for hepatotoxicity with prolonged high-dose niacinamide use 4
  • Drug interactions: Consider thiamine-depleting medications (furosemide, metformin, metronidazole) that may increase requirements 7

Management of adverse effects:

  • Most adverse effects from B vitamins are dose-dependent and resolve with dose reduction or discontinuation 4
  • If GI upset or other symptoms occur, consider reducing the niacinamide component first, as it's the highest relative to typical supplementation doses

Common pitfall: Assuming all B vitamins are universally safe at any dose. While generally well-tolerated, niacinamide at 100 mg approaches doses where monitoring becomes prudent, particularly with chronic use.

References

Research

[Thiamine treatment in psychiatry and neurology].

Fortschritte der Neurologie-Psychiatrie, 2000

Guideline

espen micronutrient guideline.

Clinical Nutrition, 2022

Research

Final report of the safety assessment of niacinamide and niacin.

International journal of toxicology, 2005

Research

Hypercobalaminemia in Outpatient Practice.

Journal of clinical medicine, 2026

Research

Adverse events associated with drug-related thiamine deficiency: A pharmacovigilance study.

JPEN. Journal of parenteral and enteral nutrition, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.